Safety, tolerability and pharmacokinetics of evinacumab, an angiopoietin-like protein 3 (ANGPTL3) inhibitor, in healthy Japanese and Caucasian subjects

Saved in:
Bibliographic Details
Published inAtherosclerosis Vol. 315; pp. e36 - e37
Main Authors Harada-Shiba, M., Ali, S., Gipe, D.A., Gasparino, E., Son, V., Pordy, R., Catapano, A.L.
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.12.2020
Online AccessGet full text

Cover

More Information
ISSN:0021-9150
1879-1484
DOI:10.1016/j.atherosclerosis.2020.10.118